Molecular Radiation Biology Group

Publications published since 1985 from OUS - Molecular Radiation Biology

127 publications found

Publications 2020

  1. Darvekar S, Juzenas P, Oksvold M, Kleinauskas A, Holien T, Christensen E, Stokke T, Sioud M, Peng Q (2020)
    Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
    Cancers (Basel), 12 (2)
    DOI 10.3390/cancers12020377, PubMed 32041351
  2. Hillestad T, Hompland T, Fjeldbo CS, Skingen VE, Salberg UB, Aarnes EK, Nilsen A, Lund KV, Evensen TS, Kristensen GB, Stokke T, Lyng H (2020)
    MR Imaging Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
    Cancer Res (in press)
    DOI 10.1158/0008-5472.CAN-20-0950, PubMed 32606004
  3. Malenge MM, Patzke S, Ree AH, Stokke T, Ceuppens P, Middleton B, Dahle J, Repetto-Llamazares AHV (2020)
    177Lu-lilotomab satetraxetan has the potential to counteract resistance to rituximab in non-Hodgkin's lymphoma
    J Nucl Med (in press)
    DOI 10.2967/jnumed.119.237230, PubMed 32245896
  4. Rein ID, Notø HØ, Bostad M, Huse K, Stokke T (2020)
    Cell Cycle Analysis and Relevance for Single-Cell Gating in Mass Cytometry
    Cytometry A
    DOI 10.1002/cyto.a.23960, PubMed 31943748
  5. Wong JJW, Berstad MB, Fremstedal ASV, Berg K, Patzke S, Sørensen V, Peng Q, Selbo PK, Weyergang A (2020)
    Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy
    Cancers (Basel), 12 (2)
    DOI 10.3390/cancers12020417, PubMed 32053965

Publications 2019

  1. Frikstad KM, Molinari E, Thoresen M, Ramsbottom SA, Hughes F, Letteboer SJF, Gilani S, Schink KO, Stokke T, Geimer S, Pedersen LB, Giles RH, Akhmanova A, Roepman R, Sayer JA, Patzke S (2019)
    A CEP104-CSPP1 Complex Is Required for Formation of Primary Cilia Competent in Hedgehog Signaling
    Cell Rep, 28 (7), 1907-1922.e6
    DOI 10.1016/j.celrep.2019.07.025, PubMed 31412255
  2. Jonsson M, Fjeldbo CS, Holm R, Stokke T, Kristensen GB, Lyng H (2019)
    Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer
    Neoplasia, 21 (4), 353-362
    DOI 10.1016/j.neo.2019.01.002, PubMed 30856376
  3. Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Bardiès M, Pouget JP (2019)
    The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest
    Leukemia, 34 (5), 1315-1328
    DOI 10.1038/s41375-019-0677-4, PubMed 31836849
  4. Rødland GE, Melhus K, Generalov R, Gilani S, Bertoni F, Dahle J, Syljuåsen RG, Patzke S (2019)
    The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines
    Front Oncol, 9, 1301
    DOI 10.3389/fonc.2019.01301, PubMed 31850205

Publications 2018

  1. Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, Patzke S, Brennhovd B, Seierstad T, Lyng H (2018)
    Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
    Cancer Res, 78 (16), 4774-4785
    DOI 10.1158/0008-5472.CAN-17-3806, PubMed 29945958
  2. Repetto-Llamazares AHV, Malenge MM, O'Shea A, Eiríksdóttir B, Stokke T, Larsen RH, Dahle J (2018)
    Combination of 177 Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphoma
    Eur J Haematol, 101 (4), 522-531
    DOI 10.1111/ejh.13139, PubMed 29993152
  3. Shearer RF, Frikstad KM, McKenna J, McCloy RA, Deng N, Burgess A, Stokke T, Patzke S, Saunders DN (2018)
    The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia
    Mol Biol Cell, 29 (13), 1542-1554
    DOI 10.1091/mbc.E17-04-0248, PubMed 29742019

Publications 2017

  1. Hauge S, Naucke C, Hasvold G, Joel M, Rødland GE, Juzenas P, Stokke T, Syljuåsen RG (2017)
    Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading
    Oncotarget, 8 (7), 10966-10979
    DOI 10.18632/oncotarget.14089, PubMed 28030798
  2. Olsen CE, Sellevold S, Theodossiou T, Patzke S, Berg K (2017)
    Impact of genotypic and phenotypic differences in sarcoma models on the outcome of photochemical internalization (PCI) of bleomycin
    Photodiagnosis Photodyn Ther, 20, 35-47
    DOI 10.1016/j.pdpdt.2017.08.010, PubMed 28838761

Publications 2016

  1. Boye E, Anda S, Rothe C, Stokke T, Grallert B (2016)
    Analyzing Schizosaccharomyces pombe DNA Content by Flow Cytometry
    Cold Spring Harb Protoc, 2016 (6)
    DOI 10.1101/pdb.prot091280, PubMed 27250946
  2. Hasvold G, Lund-Andersen C, Lando M, Patzke S, Hauge S, Suo Z, Lyng H, Syljuåsen RG (2016)
    Hypoxia-induced alterations of G2 checkpoint regulators
    Mol Oncol, 10 (5), 764-73
    DOI 10.1016/j.molonc.2015.12.015, PubMed 26791779
  3. Jonsson M, Ragnum HB, Julin CH, Yeramian A, Clancy T, Frikstad KM, Seierstad T, Stokke T, Matias-Guiu X, Ree AH, Flatmark K, Lyng H (2016)
    Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
    Br J Cancer, 115 (8), 929-939
    DOI 10.1038/bjc.2016.278, PubMed 27599042

Publications 2015

  1. Berstad MB, Cheung LH, Berg K, Peng Q, Fremstedal AS, Patzke S, Rosenblum MG, Weyergang A (2015)
    Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy
    Oncogene, 34 (44), 5582-92
    DOI 10.1038/onc.2015.15, PubMed 25684137
  2. Dale Rein I, Solberg Landsverk K, Micci F, Patzke S, Stokke T (2015)
    Replication-induced DNA damage after PARP inhibition causes G2 delay, and cell line-dependent apoptosis, necrosis and multinucleation
    Cell Cycle, 14 (20), 3248-60
    DOI 10.1080/15384101.2015.1085137, PubMed 26312527
  3. Dale Rein I, Stokke C, Jalal M, Myklebust JH, Patzke S, Stokke T (2015)
    New distinct compartments in the G2 phase of the cell cycle defined by the levels of γH2AX
    Cell Cycle, 14 (20), 3261-9
    DOI 10.1080/15384101.2015.1087617, PubMed 26317799
  4. Huang R, Wang J, Zhong Y, Liu Y, Stokke T, Trope CG, Nesland JM, Suo Z (2015)
    Mitochondrial DNA Deficiency in Ovarian Cancer Cells and Cancer Stem Cell-like Properties
    Anticancer Res, 35 (7), 3743-53
    PubMed 26124317
  5. Håland TW, Boye E, Stokke T, Grallert B, Syljuåsen RG (2015)
    Simultaneous measurement of passage through the restriction point and MCM loading in single cells
    Nucleic Acids Res, 43 (22), e150
    DOI 10.1093/nar/gkv744, PubMed 26250117
  6. Repetto-Llamazares AH, Larsen RH, Patzke S, Fleten KG, Didierlaurent D, Pichard A, Pouget JP, Dahle J (2015)
    Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
    PLoS One, 10 (6), e0128816
    DOI 10.1371/journal.pone.0128816, PubMed 26066655
  7. Sternemalm J, Geimer S, Frikstad KA, Schink KO, Stokke T, Patzke S (2015)
    CSPP-L Associates with the Desmosome of Polarized Epithelial Cells and Is Required for Normal Spheroid Formation
    PLoS One, 10 (8), e0134789
    DOI 10.1371/journal.pone.0134789, PubMed 26241740

Publications 2014

  1. Lund-Andersen C, Patzke S, Nähse-Kumpf V, Syljuåsen RG (2014)
    PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule
    Radiother Oncol, 110 (2), 355-61
    DOI 10.1016/j.radonc.2013.12.014, PubMed 24502970
  2. Ragnum HB, Vlatkovic L, Lie AK, Axcrona K, Julin CH, Frikstad KM, Hole KH, Seierstad T, Lyng H (2014)
    The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
    Br J Cancer, 112 (2), 382-90
    DOI 10.1038/bjc.2014.604, PubMed 25461803
  3. Sternemalm J, Russnes HG, Zhao X, Risberg B, Nord S, Caldas C, Børresen-Dale AL, Stokke T, Patzke S (2014)
    Nuclear CSPP1 expression defined subtypes of basal-like breast cancer
    Br J Cancer, 111 (2), 326-38
    DOI 10.1038/bjc.2014.297, PubMed 24901235

Publications 2013

  1. Heyerdahl H, Abbas N, Sponheim K, Mollatt C, Bruland Ø, Dahle J (2013)
    Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice
    Curr Radiopharm, 6 (2), 106-16
    DOI 10.2174/18744710113069990018, PubMed 23551111
  2. Heyerdahl H, Røe K, Brevik EM, Dahle J (2013)
    Modifications in dynamic contrast-enhanced magnetic resonance imaging parameters after α-particle-emitting ²²⁷Th-trastuzumab therapy of HER2-expressing ovarian cancer xenografts
    Int J Radiat Oncol Biol Phys, 87 (1), 153-9
    DOI 10.1016/j.ijrobp.2013.04.052, PubMed 23790511

Publications 2012

  1. Heyerdahl H, Abbas N, Brevik EM, Mollatt C, Dahle J (2012)
    Fractionated therapy of HER2-expressing breast and ovarian cancer xenografts in mice with targeted alpha emitting 227Th-DOTA-p-benzyl-trastuzumab
    PLoS One, 7 (8), e42345
    DOI 10.1371/journal.pone.0042345, PubMed 22879947

Publications 2011

  1. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
    Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
    Curr Radiopharm, 4 (4), 321-8
    DOI 10.2174/1874471011104040321, PubMed 22202154
  2. Dahle J, Kalanxhi E, Tisnek N (2011)
    Dosimetry of a 238Pu-based alpha-particle irradiator and its biological application in a study of the bystander effect
    Anticancer Res, 31 (6), 2113-20
    PubMed 21737630
  3. Heyerdahl H, Krogh C, Borrebæk J, Larsen Å, Dahle J (2011)
    Treatment of HER2-expressing breast cancer and ovarian cancer cells with alpha particle-emitting 227Th-trastuzumab
    Int J Radiat Oncol Biol Phys, 79 (2), 563-70
    DOI 10.1016/j.ijrobp.2010.08.038, PubMed 21195878
  4. Landsverk KS, Patzke S, Rein ID, Stokke C, Lyng H, De Angelis PM, Stokke T (2011)
    Three independent mechanisms for arrest in G2 after ionizing radiation
    Cell Cycle, 10 (5), 819-29
    DOI 10.4161/cc.10.5.14968, PubMed 21325885

Publications 2010

  1. Dahle J, Jonasdottir TJ, Heyerdahl H, Nesland JM, Borrebaek J, Hjelmerud AK, Larsen RH (2010)
    Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximab
    Eur J Nucl Med Mol Imaging, 37 (1), 93-102
    DOI 10.1007/s00259-009-1197-7, PubMed 19593562
  2. Patzke S, Redick S, Warsame A, Murga-Zamalloa CA, Khanna H, Doxsey S, Stokke T (2010)
    CSPP is a ciliary protein interacting with Nephrocystin 8 and required for cilia formation
    Mol Biol Cell, 21 (15), 2555-67
    DOI 10.1091/mbc.e09-06-0503, PubMed 20519441

Publications 2009

  1. Dahle J, Krogh C, Melhus KB, Borrebaek J, Larsen RH, Kvinnsland Y (2009)
    In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab
    Int J Radiat Oncol Biol Phys, 75 (3), 886-95
    DOI 10.1016/j.ijrobp.2009.04.062, PubMed 19679402

Publications 2008

  1. Dahle J, Bruland OS, Larsen RH (2008)
    Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
    Int J Radiat Oncol Biol Phys, 72 (1), 186-92
    DOI 10.1016/j.ijrobp.2008.05.029, PubMed 18722269
  2. Dahle J, Brunborg G, Svendsrud DH, Stokke T, Kvam E (2008)
    Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesis
    Cancer Lett, 267 (1), 18-25
    DOI 10.1016/j.canlet.2008.03.002, PubMed 18406515

Publications 2007

  1. Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH (2007)
    Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate
    Blood, 110 (6), 2049-56
    DOI 10.1182/blood-2007-01-066803, PubMed 17536011
  2. Dahle J, Krogh C, Melhus KB, Kaalhus O, Larsen RH, Stokke T (2007)
    A one-step method for determining the maximum number of bound antibodies, and the affinity and association rate constants for antibody binding
    Nucl Med Commun, 28 (9), 742-7
    DOI 10.1097/MNM.0b013e3282e2a86b, PubMed 17667754
  3. Kvinnsland Y, Stokke T, Aurlien E (2007)
    Log normal distribution of cellular uptake of radioactivity
    J Nucl Med, 48 (2), 327; author reply 327-8
    PubMed 17268032

Publications 2006

  1. Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH (2006)
    Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy
    Nucl Med Biol, 33 (2), 271-9
    DOI 10.1016/j.nucmedbio.2005.12.004, PubMed 16546683
  2. Sivertsen EA, Galteland E, Mu D, Holte H, Meza-Zepeda L, Myklebost O, Patzke S, Smeland EB, Stokke T (2006)
    Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas
    Leukemia, 20 (3), 539-42
    DOI 10.1038/sj.leu.2404094, PubMed 16437153

Publications 2005

  1. Dahle J, Kvam E, Stokke T (2005)
    Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A and B radiation
    J Carcinog, 4, 11
    DOI 10.1186/1477-3163-4-11, PubMed 16091149
  2. Dahle J, Kaalhus O, Stokke T, Kvam E (2005)
    Bystander effects may modulate ultraviolet A and B radiation-induced delayed mutagenesis
    Radiat Res, 163 (3), 289-95
    DOI 10.1667/rr3305, PubMed 15733036
  3. Dahle J, Noordhuis P, Stokke T, Svendsrud DH, Kvam E (2005)
    Multiplex polymerase chain reaction analysis of UV-A- and UV-B-induced delayed and early mutations in V79 Chinese hamster cells
    Photochem Photobiol, 81 (1), 114-9
    DOI 10.1562/2004-05-19-RA-174, PubMed 15453821
  4. Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T (2005)
    Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
    Leukemia, 19 (12), 2313-23
    DOI 10.1038/sj.leu.2403954, PubMed 16193090

Publications 2004

  1. Cunderlikova B, Kaalhus O, Cunderlik R, Mateasik A, Moan J, Kongshaug M (2004)
    pH-dependent modification of lipophilicity of porphyrin-type photosensitizers (vol 79, pg 242, 2004)
    Photochem. Photobiol., 80 (2), 373
  2. Dahle J, Kakar M, Steen HB, Kaalhus O (2004)
    Automated counting of mammalian cell colonies by means of a flat bed scanner and image processing
    Cytometry A, 60 (2), 182-8
    DOI 10.1002/cyto.a.20038, PubMed 15290719
  3. Dahle J, Kvam E (2004)
    Increased level of oxidative stress in genomically unstable cell clones
    J Photochem Photobiol B, 74 (1), 23-8
    DOI 10.1016/j.jphotobiol.2004.01.004, PubMed 15043843
  4. Kvam E, Dahle J (2004)
    Melanin synthesis may sensitize melanocytes to oxidative DNA damage by ultraviolet A radiation and protect melanocytes from direct DNA damage by ultraviolet B radiation
    Pigment Cell Res, 17 (5), 549-50
    DOI 10.1111/j.1600-0749.2004.00168.x, PubMed 15357843
  5. Landsverk KS, Lyng H, Stokke T (2004)
    The response of malignant B lymphocytes to ionizing radiation: cell cycle arrest, apoptosis and protection against the cytotoxic effects of the mitotic inhibitor nocodazole
    Radiat Res, 162 (4), 405-15
    DOI 10.1667/rr3235, PubMed 15447042

Publications 2003

  1. Dahle J, Kvam E (2003)
    Induction of delayed mutations and chromosomal instability in fibroblasts after UVA-, UVB-, and X-radiation
    Cancer Res, 63 (7), 1464-9
    PubMed 12670891

Publications 2002

  1. Galteland E, Smedshammer L, Suo Z, DeAngelis P, Stokke T (2002)
    Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number
    Leukemia, 16 (8), 1549-55
    DOI 10.1038/sj.leu.2402644, PubMed 12145697
  2. Steen HB, Stokke T (2002)
    Dye exclusion artifact in flow cytometers
    Cytometry, 47 (3), 200-5
    DOI 10.1002/cyto.10063, PubMed 11891725

Publications 2001

  1. Dahle J, Angell-Petersen E, Steen HB, Moan J (2001)
    Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis
    Photochem Photobiol, 73 (4), 378-87
    DOI 10.1562/0031-8655(2001)073<0378:beicdi>;2, PubMed 11332033
  2. Steen HB (2001)
    Flow cytometers for characterization of microorganisms
    Curr Protoc Cytom, Chapter 1, Unit 1.11
    DOI 10.1002/0471142956.cy0111s07, PubMed 18770662
  3. Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H (2001)
    Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
    Br J Cancer, 85 (12), 1900-13
    DOI 10.1054/bjoc.2001.2164, PubMed 11747333

Publications 2000

  1. Dahle J, Bagdonas S, Kaalhus O, Olsen G, Steen HB, Moan J (2000)
    The bystander effect in photodynamic inactivation of cells
    Biochim Biophys Acta, 1475 (3), 273-80
    DOI 10.1016/s0304-4165(00)00077-5, PubMed 10913826
  2. Dahle J, Mikalsen SO, Rivedal E, Steen HB (2000)
    Gap junctional intercellular communication is not a major mediator in the bystander effect in photodynamic treatment of MDCK II cells
    Radiat Res, 154 (3), 331-41
    DOI 10.1667/0033-7587(2000)154[0331:gjicin];2, PubMed 10956441
  3. Stokke T, Galteland E, Holte H, Smedshammer L, Suo Z, Smeland EB, Børresen-Dale AL, DeAngelis P, Steen HB (2000)
    Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma
    Int J Cancer, 89 (4), 313-24
    DOI 10.1002/1097-0215(20000720)89:4<313::aid-ijc1>;2-d, PubMed 10956404

Publications 1999

  1. Dahle J, Angel-Petersen E, Bagdonas S, Steen HB, Moan J (1999)
    Cooperative effects of photosensitized cell killing
    P SOC PHOTO-OPT INS, 3563, 120-124
  2. Dahle J, Steen HB, Moan J (1999)
    The mode of cell death induced by photodynamic treatment depends on cell density
    Photochem Photobiol, 70 (3), 363-7
    DOI 10.1562/0031-8655(1999)070<0363:TMOCDI>2.3.CO;2, PubMed 10483366
  3. Galteland E, Holte H, Stokke T (1999)
    c-MYC, RB-1, TP53, and centromere 8 and 17 copy number in B-cell non-Hodgkin's lymphomas assessed by dual-color fluorescence in situ hybridization
    Cytometry, 38 (2), 53-60
    DOI 10.1002/(sici)1097-0320(19990415)38:2<53::aid-cyto2>;2-s, PubMed 10323217

Publications 1998

  1. Stokke T, Holte H, Smedshammer L, Smeland EB, Kaalhus O, Steen HB (1998)
    Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas
    Br J Cancer, 77 (11), 1832-8
    DOI 10.1038/bjc.1998.304, PubMed 9667654
  2. Stokke T, Smeland EB, Kvaløy S, Holte H (1998)
    Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas
    Br J Cancer, 77 (11), 1839-41
    DOI 10.1038/bjc.1998.305, PubMed 9667655
  3. Stokke T, Solberg K, DeAngelis P, Steen HB (1998)
    Propidium iodide quenches the fluorescence of TdT-incorporated FITC-labeled dUTP in apoptotic cells
    Cytometry, 33 (4), 428-34
    DOI 10.1002/(SICI)1097-0320(19981201)33:4<428::AID-CYTO6>3.3.CO;2-W, PubMed 9845437

Publications 1997

  1. Dahle J, Kaalhus O, Moan J, Steen HB (1997)
    Cooperative effects of photodynamic treatment of cells in microcolonies
    Proc Natl Acad Sci U S A, 94 (5), 1773-8
    DOI 10.1073/pnas.94.5.1773, PubMed 9050854
  2. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM (1997)
    Different pathways to apoptosis induced by tetraphenylporphine derivatives and light in V79 cells
    P SOC PHOTO-OPT INS, 3191, 107-113
  3. Stokke T, Smedshammer L, Jonassen TS, Blomhoff HK, Skarstad K, Steen HB (1997)
    Uncoupling of the order of the S and M phases: effects of staurosporine on human cell cycle kinases
    Cell Prolif, 30 (5), 197-218
    PubMed 9420612

Publications 1996

  1. Brun A, Steen H, Sandberg S (1996)
    Erythropoietic protoporphyria: two populations of reticulocytes, with and without protoporphyrin
    Eur J Clin Invest, 26 (4), 270-8
    DOI 10.1046/j.1365-2362.1996.115274.x, PubMed 8732483
  2. Moan J, Peng QA, Iani V, Ma LW, Horobin RW, Berg K, Kongshaug M, Nesland JM (1996)
    Biodistribution, pharmacokinetic and in vivo fluorescence spectroscopic studies of photosensitizers
    P SOC PHOTO-OPT INS, 2625, 234-250

Publications 1995

  1. Kongshaug M, Cheng LS, Moan J, Morgan AR (1995)
    Binding of etiopurpurin and tin-coordinated etiopurpurin to human plasma proteins. Delivery in cremophore EL and dimethyl sulfoxide (paper II)
    Int J Biochem Cell Biol, 27 (1), 71-87
    DOI 10.1016/1357-2725(94)00054-9, PubMed 7757884
  2. Kongshaug M, Moan J (1995)
    Separation of lipoproteins, albumin and gamma-globulin by single-step ultracentrifugation of human serum. Application. I: Binding of hematoporphyrin to human serum and to albumin
    Int J Biochem Cell Biol, 27 (4), 371-84
    DOI 10.1016/1357-2725(94)00088-s, PubMed 7540498
  3. Kongshaug M, Moan J, Cheng LS, Morgan AR (1995)
    Binding of etiopurpurin to human plasma proteins. Delivery in cremophor EL and dimethyl sulphoxide. III
    Int J Biochem Cell Biol, 27 (5), 481-92
    DOI 10.1016/1357-2725(95)00011-d, PubMed 7641077

Publications 1994

  1. Steen HB, Jernaes MW, Skarstad K, Boye E (1994)
    Staining and measurement of DNA in bacteria
    Methods Cell Biol, 42 Pt B, 477-87
    DOI 10.1016/s0091-679x(08)61091-2, PubMed 7533253

Publications 1993

  1. Kongshaug M, Moan J, Cheng LS, Garbo GM, Kolboe S, Morgan AR, Rimington C (1993)
    Binding of drugs to human plasma proteins, exemplified by Sn(IV)-etiopurpurin dichloride delivered in cremophor and DMSO
    Int J Biochem, 25 (5), 739-60
    DOI 10.1016/0020-711x(93)90362-i, PubMed 8349016
  2. Steen HB, Sørensen OI (1993)
    Pulse modulation of the excitation light source boosts the sensitivity of an arc lamp-based flow cytometer
    Cytometry, 14 (2), 115-22
    DOI 10.1002/cyto.990140203, PubMed 8440146
  3. Stokke T, Erikstein BK, Smedshammer L, Boye E, Steen HB (1993)
    The retinoblastoma gene product is bound in the nucleus in early G1 phase
    Exp Cell Res, 204 (1), 147-55
    DOI 10.1006/excr.1993.1019, PubMed 8416792

Publications 1992

  1. Kongshaug M (1992)
    Distribution of tetrapyrrole photosensitizers among human plasma proteins
    Int J Biochem, 24 (8), 1239-65
    DOI 10.1016/0020-711x(92)90200-k, PubMed 1644211
  2. Steen HB (1992)
    Noise, sensitivity, and resolution of flow cytometers
    Cytometry, 13 (8), 822-30
    DOI 10.1002/cyto.990130804, PubMed 1458999
  3. Stokke T, Holte H, Smeland EB, Lie SO, Steen HB (1992)
    Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells
    Cancer Res, 52 (18), 5007-12
    PubMed 1516056

Publications 1991

  1. Kongshaug M, Cheng LS, Moan J, Rimington C (1991)
    Interaction of cremophor EL with human plasma
    Int J Biochem, 23 (4), 473-8
    DOI 10.1016/0020-711x(91)90176-n, PubMed 2015955
    Int. J. Biochem., 23 (12), 1411-1416
    Int. J. Biochem., 23 (4), 435-442
  4. Stokke T, Erikstein B, Holte H, Funderud S, Steen HB (1991)
    Cell cycle-specific expression and nuclear binding of DNA polymerase alpha
    Mol Cell Biol, 11 (6), 3384-9
    DOI 10.1128/mcb.11.6.3384, PubMed 2038340

Publications 1990

  1. Kongshaug M, Rimington C, Evensen JF, Peng Q, Moan J (1990)
    Hematoporphyrin diethers--V. Plasma protein binding and photosensitizing efficiency
    Int J Biochem, 22 (10), 1127-31
    DOI 10.1016/0020-711x(90)90110-o, PubMed 2149708
  2. Steen HB (1990)
    Applications of flow cytometry in clinical analysis
    Scand J Clin Lab Invest Suppl, 202, 36-7
    PubMed 2075441
  3. Steen HB (1990)
    Light scattering measurement in an arc lamp-based flow cytometer
    Cytometry, 11 (2), 223-30
    DOI 10.1002/cyto.990110202, PubMed 2180652
  4. Steen HB, Skarstad K, Boye E (1990)
    DNA measurements of bacteria
    Methods Cell Biol, 33, 519-26
    DOI 10.1016/s0091-679x(08)60551-8, PubMed 2084483

Publications 1989

  1. Kongshaug M, Moan J, Brown SB (1989)
    The distribution of porphyrins with different tumour localising ability among human plasma proteins
    Br J Cancer, 59 (2), 184-8
    DOI 10.1038/bjc.1989.38, PubMed 2930683
    Int. J. Biochem., 21 (10), 1177-&
    BIOCHIM BIOPHYS ACTA, 992 (2), 241-242

Publications 1988

  1. Stokke T (1988)
    Re: L. F. Pearlman et al., interaction of three second-generation anthracyclines with polynucleotides, RNA, DNA, and nucleosomes. Cancer Res., 46:341-346, 1986
    Cancer Res, 48 (23), 6962-5
    PubMed 2460232
  2. STOKKE T (1988)
    Cancer Res., 48 (23), 6962-6963
  3. Stokke T, Holte H, Steen HB (1988)
    In vitro and in vivo activation of B-lymphocytes: a flow cytometric study of chromatin structure employing 7-aminoactinomycin D
    Cancer Res, 48 (23), 6708-14
    PubMed 3263191

Publications 1987

    INORG CHIM A-BIOINOR, 137 (1-2), 105-107
  2. Erikstein BK, Melsom H, Borge L, Kaalhus O (1987)
    [Recurrence of breast cancer. Clinical signs and prognosis]
    Tidsskr Nor Laegeforen, 107 (5), 454-6
    PubMed 3576529
  3. Fosså SD, Borge L, Aass N, Johannessen NB, Stenwig AE, Kaalhus O (1987)
    The treatment of advanced metastatic seminoma: experience in 55 cases
    J Clin Oncol, 5 (7), 1071-7
    DOI 10.1200/JCO.1987.5.7.1071, PubMed 2439660
  4. Fosså SD, Reitan JB, Ous S, Kaalhus O (1987)
    Life with an ileal conduit in cystectomized bladder cancer patients: expectations and experience
    Scand J Urol Nephrol, 21 (2), 97-101
    DOI 10.3109/00365598709180301, PubMed 3616512
  5. Fosså SD, Urnes T, Kaalhus O (1987)
    Weekly low-dose adriamycin in hormone-resistant metastatic cancer of the prostate
    Scand J Urol Nephrol, 21 (1), 13-6
    DOI 10.3109/00365598709180283, PubMed 2438753
  6. Holte H, Davies CD, Kvaløy S, Smeland EB, Foss-Abrahamsen A, Kaalhus O, Marton PF, Godal T (1987)
    The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas
    Int J Cancer, 39 (5), 590-4
    DOI 10.1002/ijc.2910390508, PubMed 3106247
  7. Sager EM, Fossä SD, Kaalhus O, Talle K (1987)
    Contrast-enhanced computed tomography in carcinoma of the urinary bladder. The use of different injection methods
    Acta Radiol, 28 (1), 67-70
    PubMed 2952145
  8. Stokke T, Steen HB (1987)
    Distinction of leucocyte classes based on chromatin-structure-dependent DNA-binding of 7-aminoactinomycin D
    Cytometry, 8 (6), 576-83
    DOI 10.1002/cyto.990080608, PubMed 2448092

Publications 1986

  1. Borthne A, Kjellevold K, Kaalhus O, Vermund H (1986)
    Salivary gland malignant neoplasms: treatment and prognosis
    Int J Radiat Oncol Biol Phys, 12 (5), 747-54
    DOI 10.1016/0360-3016(86)90032-5, PubMed 3710859
  2. Fosså SD, Aass N, Kaalhus O, Klepp O, Tveter K (1986)
    Long-term survival and morbidity in patients with metastatic malignant germ cell tumors treated with cisplatin-based combination chemotherapy
    Cancer, 58 (12), 2600-5
    DOI 10.1002/1097-0142(19861215)58:12<2600::aid-cncr2820581208>;2-d, PubMed 3022908
  3. Skarstad K, Boye E, Steen HB (1986)
    Timing of initiation of chromosome replication in individual Escherichia coli cells
    EMBO J, 5 (7), 1711-7
    DOI 10.1002/j.1460-2075.1986.tb04415.x, PubMed 3527695
  4. Steen HB (1986)
    Simultaneous separate detection of low angle and large angle light scattering in an arc lamp-based flow cytometer
    Cytometry, 7 (5), 445-9
    DOI 10.1002/cyto.990070509, PubMed 3757693
  5. Steen HB, Skarstad K, Boye E (1986)
    Flow cytometry of bacteria: cell cycle kinetics and effects of antibiotics
    Ann N Y Acad Sci, 468, 329-38
    DOI 10.1111/j.1749-6632.1986.tb42050.x, PubMed 2942091
  6. Steen HB, Stokke T (1986)
    Fluorescence spectra of cells stained with a DNA-specific dye, measured by flow cytometry
    Cytometry, 7 (1), 104-6
    DOI 10.1002/cyto.990070117, PubMed 2419053
  7. Stokke T, Steen HB (1986)
    Fluorescence spectra of Hoechst 33258 bound to chromatin
    Biochim Biophys Acta, 868 (1), 17-23
    DOI 10.1016/0167-4781(86)90081-3, PubMed 2428400
  8. Stokke T, Steen HB (1986)
    Binding of Hoechst 33258 to chromatin in situ
    Cytometry, 7 (3), 227-34
    DOI 10.1002/cyto.990070302, PubMed 2423306
  9. Thorud E, Fosså SD, Vaage S, Kaalhus O, Knudsen OS, Børmer O, Shoaib MC (1986)
    Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics
    Cancer, 57 (4), 808-11
    DOI 10.1002/1097-0142(19860215)57:4<808::aid-cncr2820570421>;2-#, PubMed 3943014
  10. Aamdal S, Fodstad O, Kaalhus O, Pihl A (1986)
    Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors
    Int J Cancer, 37 (4), 579-87
    DOI 10.1002/ijc.2910370417, PubMed 3957463

Publications 1985

  1. Fosså SD, Kaalhus O (1985)
    [Radiotherapy. Locally advanced colorectal cancer with and without 5-fluorouracil]
    Tidsskr Nor Laegeforen, 105 (6), 423-6
    PubMed 3983943
  2. Fosså SD, Kaalhus O (1985)
    The prognostic relevance of nuclear Feulgen DNA in transitional cell carcinoma of the urinary bladder. A long-term follow-up study
    Eur Urol, 11 (6), 418-21
    DOI 10.1159/000472553, PubMed 2417858
  3. Godal T, Davies C, Smeland EB, Heikkilä R, Funderud S, Steen HB, Hildrum K (1985)
    Antibodies to surface IgM and IgD increase the expression of various class II antigens on human B cells
    Eur J Immunol, 15 (2), 173-7
    DOI 10.1002/eji.1830150212, PubMed 3871699
  4. Kogoma T, Skarstad K, Boye E, von Meyenburg K, Steen HB (1985)
    RecA protein acts at the initiation of stable DNA replication in rnh mutants of Escherichia coli K-12
    J Bacteriol, 163 (2), 439-44
    DOI 10.1128/JB.163.2.439-444.1985, PubMed 2991187
  5. Kvaløy S, Langholm R, Kaalhus O, Marton PF, Høst H, Godal T (1985)
    Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement receptor--their relationship to survival
    Scand J Haematol, 35 (2), 137-44
    DOI 10.1111/j.1600-0609.1985.tb01562.x, PubMed 3876595
  6. Kvaløy S, Marton PF, Kaalhus O, Høie J, Foss-Abrahamsen A, Godal T (1985)
    3H-thymidine uptake in B cell lymphomas--relationship to treatment response and survival
    Scand J Haematol, 34 (5), 429-35
    DOI 10.1111/j.1600-0609.1985.tb00773.x, PubMed 3925545
  7. Reitan JB, Kaalhus O, Brennhovd IO, Sager EM, Stenwig AE, Talle K (1985)
    Prognostic factors in liposarcoma
    Cancer, 55 (10), 2482-90
    DOI 10.1002/1097-0142(19850515)55:10<2482::aid-cncr2820551029>;2-r, PubMed 3986744
  8. Skarstad K, Steen HB, Boye E (1985)
    Escherichia coli DNA distributions measured by flow cytometry and compared with theoretical computer simulations
    J Bacteriol, 163 (2), 661-8
    DOI 10.1128/JB.163.2.661-668.1985, PubMed 3894332
  9. Steen HB, Lindmo T (1985)
    Differential of light-scattering detection in an arc-lamp-based epi-illumination flow cytometer
    Cytometry, 6 (4), 281-5
    DOI 10.1002/cyto.990060402, PubMed 4017793
  10. Stokke T, Steen HB (1985)
    Multiple binding modes for Hoechst 33258 to DNA
    J Histochem Cytochem, 33 (4), 333-8
    DOI 10.1177/33.4.2579998, PubMed 2579998
  11. Stokke T, Steen HB (1985)
    Neither adriamycin nor actinomycin D displaces Tb3+ from DNA
    Biochim Biophys Acta, 825 (4), 416-8
    DOI 10.1016/0167-4781(85)90070-3, PubMed 4016123
  12. Vermund H, Kaalhus O, Winther F, Trausjø J, Thorud E, Harang R (1985)
    Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial
    Int J Radiat Oncol Biol Phys, 11 (11), 1877-86
    DOI 10.1016/0360-3016(85)90267-6, PubMed 2414253
Page visits: 6016